Tower Research Capital LLC (Trc) Enochian Biosciences Inc Transaction History

Tower Research Capital LLC (Trc)

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.91 - $1.31 $2,605 - $3,750	2,863 Added 37.28%	10,543 $10,000
Q4 2022 Feb 10, 2023	BUY	$1.03 - $2.13 $3,291 - $6,807	3,196 Added 71.28%	7,680 $8,000
Q3 2022 Nov 10, 2022	SELL	$1.7 - $2.86 $3,005 - $5,056	-1,768 Reduced 28.28%	4,484 $8,000
Q2 2022 Aug 15, 2022	BUY	$1.93 - $8.73 $4,608 - $20,847	2,388 Added 61.8%	6,252 $12,000
Q1 2022 May 12, 2022	SELL	$4.42 - $9.0 $27,178 - $55,341	-6,149 Reduced 61.41%	3,864 $32,000
Q4 2021 Feb 14, 2022	BUY	$6.71 - $12.55 $67,187 - $125,663	10,013 New	10,013 $73,000
Q2 2021 Aug 16, 2021	SELL	$2.94 - $6.79 $9,552 - $22,060	-3,249 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.02 - $4.51 $9,244 - $13,805	-3,061 Reduced 48.51%	3,249 $12,000
Q4 2020 Feb 16, 2021	SELL	$2.82 - $3.55 $27,410 - $34,506	-9,720 Reduced 60.64%	6,310 $19,000
Q3 2020 Nov 16, 2020	BUY	$3.42 - $4.55 $42,944 - $57,134	12,557 Added 361.56%	16,030 $57,000
Q2 2020 Aug 13, 2020	BUY	$2.78 - $6.06 $9,654 - $21,046	3,473 New	3,473 $15,000
Q1 2020 May 15, 2020	SELL	$2.08 - $5.41 $15,995 - $41,602	-7,690 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$3.48 - $6.75 $26,761 - $51,907	7,690 New	7,690 $39,000
Q3 2019 Nov 05, 2019	SELL	$3.95 - $5.72 $6,268 - $9,077	-1,587 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$4.5 - $6.99 $7,119 - $11,058	1,582 Added 31640.0%	1,587 $8,000
Q1 2019 May 14, 2019	SELL	$5.82 - $9.25 $104 - $166	-18 Reduced 78.26%	5 $0
Q4 2018 Feb 14, 2019	BUY	$5.17 - $8.48 $118 - $195	23 New	23 $0

14M

33.7K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.